Danaher Corp
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Consolidated Adjusted EBITDA by Year
Consolidated Adjusted EBITDA (Non-GAAP Supplemental Data) ($M)
Danaher Consolidated Adjusted EBITDA: $7,689M in FY2025, up 1.7% from a year earlier.
Where the FY2025 figure comes from
Source: Danaher IR — nongaap_2025Q4 ↗
Disclosed in the Segment Overview table of Non-GAAP Reconciliations & Supplemental Data (fills gap where EBITDA ended in FY2023 and had no quarterly figures).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated Adjusted EBITDA (Non-GAAP Supplemental Data) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,689 | +1.7% | Danaher IR — nongaap_2025Q4 ↗ |
| FY2024 | Dec 31, 2024 | 7,561 | +0.4% | Danaher IR — nongaap_2025Q4 ↗ |
| FY2023 | Dec 31, 2023 | 7,530 | -22.5% | Danaher IR — nongaap_2024Q4 ↗ |
| FY2022 | Dec 31, 2022 | 9,710 | +6.7% | Danaher IR — nongaap_ex_veralto ↗ |
| FY2021 | Dec 31, 2021 | 9,100 | – | Danaher IR — nongaap_ex_veralto ↗ |
Breakdown
What makes up consolidated Adjusted EBITDA
- Biotechnology — Adjusted EBITDA3,016 · FY2025
- Life Sciences — Adjusted EBITDA1,755 · FY2025
- Diagnostics — Adjusted EBITDA3,253 · FY2025
- Other / Corporate — Adjusted EBITDA-335 · FY2025
- Biên Adjusted EBITDA toàn công ty (Adjusted EBITDA Margin)31.3% · FY2025
- Biotechnology — Biên Adjusted EBITDA41.4% · FY2025
- Life Sciences — Biên Adjusted EBITDA23.9% · FY2025
- Diagnostics — Biên Adjusted EBITDA32.7% · FY2025
Cite this data
StockData. (2026). Danaher Consolidated Adjusted EBITDA ($M), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/adj-ebitda-total
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.